書籍情報から探す
Improving and Protecting Effect and Safety of Mexiletine Hydrochrolide or Mianserin Hydrochloride on Painful Diabetic Neuropathy in Patients with Type 2 Diabetes Mellitus for 2 years in Prospective Randomized Well-controlled Comparative Study
Yoshio Nishizawa1, 2, 3), Yasuko Nishizawa4, 5), Fumi Yoshioka6), Syuichi Nosaka3), Yoshikuni Amakata7), Shinji Fushiki2)
The Department of Endocrinology, Nishizawa Clinic1), Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Department of pathology and Applied Neurobiology2), The Department of Anesthresiology, Siga University of Medical Science3), Department of Pathology, Osaka Medical Center for Cancer and Cardiovascular Diseases4), Department of Clinical and Experimental Pathophysiology, Graduate School of Pharmaceutical Science, Osaka University5), The Department of Internal Medicine, Sato Hospital6), Suminoe Hospital Nakayama Foundation7)
The journal of Japanese Society for Study of Chronic Pain 24 (1) 137-148, 2005.
The Department of Endocrinology, Nishizawa Clinic1), Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Department of pathology and Applied Neurobiology2), The Department of Anesthresiology, Siga University of Medical Science3), Department of Pathology, Osaka Medical Center for Cancer and Cardiovascular Diseases4), Department of Clinical and Experimental Pathophysiology, Graduate School of Pharmaceutical Science, Osaka University5), The Department of Internal Medicine, Sato Hospital6), Suminoe Hospital Nakayama Foundation7)
The journal of Japanese Society for Study of Chronic Pain 24 (1) 137-148, 2005.
- アブストラクト: 従量制は110円(税込)、基本料金制は基本料金に含まれます。
- 全文ダウンロード: 従量制、基本料金制の方共に770円(税込) です。
Efficacy of a Selective Antagonist of 5-HT2A Receptor, Sarpogrelate Hydrochloride, Compared with Prostaglandin I2 Derivative, Beraprost Sodium, on Painful Diabetic Neuropathy in Patients with Type 2 Diabetic Mellitus in Prospective Randomized Well-Controlled Comparative Study.
Yoshio Nishizawa1, 2, 3), Yasuko Nishizawa4, 5), Fumi Yoshioka6), Syuichi Nosaka3), Yoshikuni Amakata7), Shinji Fushiki2)
The Department of Endocrinology, Nishizawa Clinic1), Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Department of pathology and Applied Neurobiology2), The Department of Anesthresiology, Siga University of Medical Science3), Department of Pathology, Osaka Medical Center for Cancer and Cardiovascular Diseases4), Department of Clinical and Experimental Pathophysiology, Graduate School of Pharmaceutical Science, Osaka University5), The Department of Internal Medicine, Sato Hospital6), Suminoe Hospital Nakayama Foundation7)
The journal of Japanese Society for Study of Chronic Pain 24 (1) 149-158, 2005.
The Department of Endocrinology, Nishizawa Clinic1), Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Department of pathology and Applied Neurobiology2), The Department of Anesthresiology, Siga University of Medical Science3), Department of Pathology, Osaka Medical Center for Cancer and Cardiovascular Diseases4), Department of Clinical and Experimental Pathophysiology, Graduate School of Pharmaceutical Science, Osaka University5), The Department of Internal Medicine, Sato Hospital6), Suminoe Hospital Nakayama Foundation7)
The journal of Japanese Society for Study of Chronic Pain 24 (1) 149-158, 2005.
- アブストラクト: 従量制は110円(税込)、基本料金制は基本料金に含まれます。
- 全文ダウンロード: 従量制、基本料金制の方共に770円(税込) です。